Ilexgenin A 是从海南冬青中提取的一种五环三萜类化合物。Ilexgenin A 可用于炎症和癌症研究。
生物活性 | Ilexgenin A is a pentacyclic triterpenoid, which extracted fromIlex hainanensisMerr.Ilexgenin A can be used for the research of inflammation andcancer[1]. |
体外研究 (In Vitro) | Ilexgenin A (0~100 μM; 24 hours; HT 29 and HCT 116 cells) effectively decreases cell viability in HT 29 and HCT 116 cells[1]. Ilexgenin A (12.5~50 μM; 24 hours; HT 29 cells) downregulates the expression of SREBP-1, inhibits the translocation of SREBP-1 to the nucleus and decreases the content of TG[1]. Ilexgenin A (12.5~50 μM; HT 29 and HCT 116 cells) induces cell cycle arrest at G1 phase in colon cancer cells[1]. Ilexgenin A (12.5~50 μM; 24 hours; HCT 116 cells) modulates lipid metabolism. Ilexgenin A (50 μM; 24 hours; HT 29 and HCT 116 cells) regulates SREBP-1 by inhibiting HIF1α[1]. Ilexgenin A inhibits fatty acids synthesis[1].
Cell Viability Assay[1] Cell Line: | HT 29 and HCT 116 cells | Concentration: | 0~100 μM | Incubation Time: | 24 hours | Result: | Effectively decreased cell viability in HT 29 and HCT 116 cells. |
Western Blot Analysis[1] Cell Line: | HT 29 cells | Concentration: | 12.5~50 μM | Incubation Time: | 24 hours | Result: | Downregulated the expression of SREBP-1. |
RT-PCR[1] Cell Line: | HT 29 cells | Concentration: | 12.5~50 μM | Incubation Time: | 24 hours | Result: | Decreased the content of TG. |
Immunofluorescence[1] Cell Line: | HT 29 cells | Concentration: | 12.5~50 μM | Incubation Time: | 24 hours | Result: | Inhibited the translocation of SREBP-1 to the nucleus. |
|
体内研究 (In Vivo) | Ilexgenin A (20 mg/kg) ameliorates the AOM/DSS induced carcinogenesis. Ilexgenin A can regulate lipid metabolism. Ilexgenin A decreases the expression of SREBP-1 and HIF 1α in AOM/DSS mice[1].
|
分子量 | |
性状 | |
Formula | |
CAS 号 | |
结构分类 | |
来源 | - Plants
- Aquifoliaceae
- Ilex hainanensisMerr.
|
运输条件 | Room temperature in continental US; may vary elsewhere. |
储存方式 | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
溶解性数据 | In Vitro: DMSO : 100 mg/mL(198.93 mM;Need ultrasonic) 配制储备液 1 mM | 1.9893 mL | 9.9467 mL | 19.8934 mL | 5 mM | 0.3979 mL | 1.9893 mL | 3.9787 mL | 10 mM | 0.1989 mL | 0.9947 mL | 1.9893 mL |
*请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (protect from light)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百 分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 1. 请依序添加每种溶剂: 10% DMSO 40%PEG300 5%Tween-80 45% saline Solubility: 2.5 mg/mL (4.97 mM); Suspended solution; Need ultrasonic
此方案可获得 2.5 mg/mL (4.97 mM) 的均匀悬浊液,悬浊液可用于口服和腹腔注射。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。 2. 请依序添加每种溶剂: 10% DMSO 90%corn oil Solubility: ≥ 2.5 mg/mL (4.97 mM); Clear solution
此方案可获得 ≥ 2.5 mg/mL (4.97 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。 以 1 mL 工作液为例,取 100 μL 25.0 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。 *以上所有助溶剂都可在本网站选购。
|